Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Entresto (Sacubitril/Valsartan) for the Treatment of Heart Failure

Drug Name (Brand / Generic)

Entresto (Sacubitril/Valsartan)

Company / Licensee

Novartis

Current Indication

Heart failure

Therapy Class

Angiotensin receptor neprilysin inhibitor (ARNI)

Market Sector

Cardiovascular

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top